Table 8 Stratified analysis of LINC02122 polymorphism rs12516079 and prognosis of GC
From: lncRNA polymorphism affects the prognosis of gastric cancer
rs12516079 | ≦65 | >65 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stages I–III | Stage IV | Stages I–III | Stage IV | |||||||||
N | MST (M) | HR (95% CI) | N | MST (M) | HR (95% CI) | N | MST (M) | HR (95% CI) | N | MST (M) | HR (95% CI) | |
Codominance | ||||||||||||
 AA | 11 | 75.08 | 1 | 2 | 4.00 | 1 | 15 | 75.00 | 1 | 10 | 8.00 | 1 |
 AG | 35 | 105.48 | 1.665 (0.459–6.031) | 13 | 13.00 | 0.511 (0.103–2.528) | 57 | 46.00 | 0.997 (0.432–2.297) | 42 | 8.00 | 1.022 (0.483–2.164) |
 GG | 44 | 71.86 | 1.420 (0.400–5.035) | 15 | 12.00 | 0.522 (0.107–2.541) | 55 | 117.32 | 0.535 (0.217–1.32) | 45 | 10.00 | 0.729 (0.350–1.519) |
Dominant model | ||||||||||||
 AA | 11 | 75.08 | 1 | 2 | 4.00 | 1 | 15 | 75.00 | 1 | 10 | 8.00 | 1 |
 AG+GG | 79 | 101.38 | 1.522 (0.452–5.127) | 28 | 12.00 | 0.517 (0.112–2.391) | 112 | 81.00 | 0.767 (0.343–1.715) | 87 | 9.00 | 0.837 (0.414–1.692) |
Recessive model | ||||||||||||
 AA+AG | 46 | 73.00 | 1 | 15 | 13.00 | 1 | 72 | 46.00 | 1 | 52 | 8.00 | 1 |
 GG | 44 | 71.86 | 0.965 (0.462–2.016) | 15 | 12.00 | 0.941 (0.416–2.132) | 55 | 117.32 | 0.536 (0.291–0.987) | 45 | 10.00 | 0.717 (0.465–1.106) |